Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Daniel, Peter Prof. Dr. (1) Janz, Martin Dr. (5) Kammertöns, Thomas Dr. (1) Leisegang, Matthias Prof. Dr. rer. nat. (1) Lusatis, Simone (1) Mathas, Stephan Dr. (5) Pezzutto, Antonio Prof. Dr. (1) Scheidereit, Claus Prof. Dr. (1) Selbach, Matthias Prof. Dr. (4) Uckert, Wolfgang Prof. Dr. (1) (-) Blankenstein, Thomas Prof. Dr. (3) (-) Wollert-Wulf, Brigitte (2) 1992 (4) 1993 (7) 1995 (8) 1996 (6) 1997 (9) 1998 (9) (-) 1999 (2) 2000 (8) 2003 (9) 2004 (8) 2005 (10) (-) 2006 (3) 2009 (2) 2010 (7) 2012 (6) 2013 (13) 2014 (4) 2015 (4) 2016 (4) 2017 (6) 2018 (4) 2019 (6) 2021 (4) 2022 (6) 2023 (6) 2024 (2) (-) Biology of Malignant Lymphomas (2) Genetics and Genomics of Cardiovascular Diseases (1) (-) Molecular Immunology and Gene Therapy (3) 5 Results: Active Filter: Blankenstein, Thomas Prof. Dr.Wollert-Wulf, BrigitteBiology of Malignant LymphomasMolecular Immunology and Gene Therapy19992006 Sort: Result score Newest to oldest Oldest to newest January 01, 1999 / Eur J Immunol Direct and indirect T cell priming by dendritic cell vaccines S. Cayeux G. Richter C. Becker A. Pezzutto B. Doerken T. Blankenstein March 01, 1999 / J Exp Med T helper cell type 1-associated and cytotoxic T lymphocyte-mediated tumor immunity is impaired in interleukin 4-deficient mice T. Schueler Z. Qin S. Ibe N. Noben-Trauth T. Blankenstein November 01, 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert March 15, 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou February 01, 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
January 01, 1999 / Eur J Immunol Direct and indirect T cell priming by dendritic cell vaccines S. Cayeux G. Richter C. Becker A. Pezzutto B. Doerken T. Blankenstein
March 01, 1999 / J Exp Med T helper cell type 1-associated and cytotoxic T lymphocyte-mediated tumor immunity is impaired in interleukin 4-deficient mice T. Schueler Z. Qin S. Ibe N. Noben-Trauth T. Blankenstein
November 01, 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
March 15, 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
February 01, 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken